Company / Profit Margin
Century Therapeutics, Inc. Profit Margin History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-1920.9%
FY2025
5-year range
-6115.1% / -1843.1%
FY2022-FY2025
Trend
+68.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin returned to growth in FY2025 after 2 years of decline, reaching -1920.9%.
Based on SEC 10-K filings.
-1920.9% in FY2025 with a 3-year CAGR of -77.7%.
Improved from -2518.4% to -1920.9% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -77.7pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin increased 68.6% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -1920.9% | +68.6% |
| FY2024 | -6115.1% | -142.8% |
| FY2023 | -2518.4% | -36.6% |
| FY2022 | -1843.1% | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026